EGFR and neoplasm: To study the clonality of tumor cells in central lesions, cell-free DNA was extracted from the spinal fluid (Fig. 3A), and amplicon target sequencing was performed on EGFR Ex.19 deletions, which revealed an E746_A750 deletion at a variant allele frequency of 29.2 % (Fig. 3B).